This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Intuniv XR (2017-04-21)

Starting date:
April 21, 2017
Posting date:
June 22, 2017
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-63716

Reason

Affected lot may be associated with adverse reaction that may be linked to potential Digoxin contamination.

Depth of distribution

Healthcare professionals across Canada

Affected products

Intuniv XR

DIN, NPN, DIN-HIM

DIN 02409119

Dosage form

Tablet (Extended-Release)

Strength

2 mg Guanfacine (Guanfacine hydrochloride)

Lot or serial number

AF6131D

Companies

Recalling Firm
Shire Pharma Canada ULC
2250 Alfred-Nobel Blvd, suite 500
Saint-Laurent
H4S 2C9
Quebec
CANADA
Marketing Authorization Holder
Shire Pharma Canada ULC
2250 Alfred-Nobel Blvd, suite 500
Saint-Laurent
H4S 2C9
Quebec
CANADA

Date modified: